NetApp Shorts Retreat as Analysts Diverge
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
NetApp has dropped 16% in a week to $190.78, yet short sellers are quietly reducing exposure, creating an unusual gap between the stock's sharp fall and what the positioning data actually shows.
The lending market tells a story of retreating conviction, not mounting pressure. Short interest has fallen 24% over the past month to 3.96% of the free float, roughly 7.8 million shares, its lowest level in this 30-day window. That unwind accelerated through mid-October, when SI was running above 13 million shares, and has continued in each of the past two weeks. Borrowing costs reflect that retreat: the cost to borrow has dropped 39% over the week to 0.33%, a low reading by any measure. Availability is extraordinarily loose, at 2,875%, meaning there are nearly 29 shares available to borrow for every one currently lent out. This is not a market under squeeze pressure. It is one where short sellers are stepping back even as the stock falls.
Options positioning is modestly more cautious. The put/call ratio has crept to 0.85, about 1.3 standard deviations above its 20-day mean of 0.82. That is a mild defensive tilt, not a panic reading. At the 52-week extremes, the PCR has ranged from 0.23 to 1.03, so the current level sits in the upper quartile but nowhere near the year's high. What it suggests is that investors are buying incremental protection without rushing to it. The ORTEX short score of 37 sits in the 40th percentile against the broader market, consistent with the picture: nothing extreme, nothing signalling forced conviction either way.
The Street is genuinely split, and the recent moves are worth parsing. Evercore ISI upgraded NTAP to Outperform on October 7, lifting its target from $210 to $300, the most bullish call in this period. TD Cowen followed with a Buy reiteration and raised to $250, and Loop Capital moved to $260. Set against that, Barclays downgraded from Overweight to Equal-Weight on October 14, keeping its target at $219, and Guggenheim initiated at Neutral last week without attaching a price target. BofA stayed Neutral but raised to $220. The resulting consensus is 13 Holds and a smattering of Buys, making the analyst debate genuinely unresolved. The trailing PE has contracted 3.3 points over the past 30 days to 17.4x, while price-to-book has shed 2.9 points to 14.4x. Those moves reflect the stock's slide more than any fundamental re-rating, but they frame the valuation question that earnings on December 1 will need to answer.
The bull and bear cases are precise enough to frame the debate cleanly. Bulls point to FQ1 product revenue of $987 million, up 51% year-over-year, all-flash arrays hitting a record $1.309 billion, and 11 consecutive quarters of revenue growth, with FY2027 guidance raised to a revenue range of $7.975 to $8.225 billion and EPS of $9.73 to $10.03. Bears counter that product gross margins fell 150 basis points sequentially, non-GAAP gross margin guidance of 67.5% implies a further 310 basis points step-down, and China tariff and export-control uncertainty alongside cloud cannibalization of on-premise demand could limit the company's ability to hold those numbers. At 17x trailing earnings with that level of margin guidance uncertainty, the gap between the upgrade camp and the downgrade camp is essentially a bet on whether the gross margin compression is cyclical or structural.
The insider filings from October 15 add no strong signal in either direction. The CEO, CFO, President and Chief Product Officer all exercised options and withheld shares for taxes on the same day at $222.20. These are compensation mechanics rather than discretionary trades, and the stock was trading roughly $30 above where it closed this week. Net insider activity over the past 90 days shows a sale-heavy balance of around 175,000 shares, but the composition is dominated by tax-withholding filings rather than open-market disposals. The peer group moved in lockstep this week: HPE fell 13%, DELL dropped 19%, and SMCI was down 11%, confirming the week's move in NTAP was a sector-wide repricing rather than company-specific news.
Wikipedia attention for NTAP registered a z-score of 2.4 against its own 90-day history as of late October, the highest retail attention reading in the period. That spike coincides with the FQ1 earnings announcement, not a leading indicator, but it reflects the degree to which the results were the week's focal point and drew attention proportionate to the magnitude of the guidance story.
With earnings set for December 1 and the stock now trading at $190.78, well below the most bearish analyst target of $171 from UBS and squarely at Citi's $190 target, the December print becomes the first real checkpoint for whether the gross margin reset was priced in or whether it marks the beginning of a more sustained compression.
Stocks in this article
See the live data behind this article on ORTEX.
Open NTAP on ORTEX →How this article was generated
- Generated
- 4 Nov 2026, 19:35
- Data as of
- 4 Nov 2026, 19:33
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.